Mesenchymal Stem Cells for COPD

Palo Alto (17 mi)

Overseen byJorge M Mallea, MD

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Phase 1

Waitlist Available

Sponsor: Mayo Clinic

No Placebo Group

Trial Summary

What is the purpose of this trial?This study is evaluating whether mesenchymal stem cells therapy may help improve lung function for individuals with chronic obstructive pulmonary disease.

Eligibility Criteria

Adults with advanced COPD who've had a flare-up in the last year, have quit smoking for at least six months, and have specific lung function test results. They must not be pregnant or breastfeeding, have a history of certain diseases like cancer or autoimmune disorders, recent infections requiring antibiotics, or severe heart issues.

Treatment Details

The trial is exploring the effects of mesenchymal stem cells on patients with advanced chronic obstructive pulmonary disease (COPD) to see if this therapy can improve their lung function and quality of life.

1Treatment groups

Experimental Treatment

Group I: Subjects with Advanced Chronic Obstructive Pulmonary DiseaseExperimental Treatment1 Intervention

Subjects diagnosed with severe or very severe COPD will be infused intravenously with Mesenchymal Stem Cells (MSC)